INTRODUCTION
============

Crohn\'s disease (CD) is a chronic, lifelong disease with uncertain etiology and a pathophysiology that can affect any gastrointestinal site from the mouth to the anal canal. Disease onset usually occurs during adolescence and patients often experience severe disease flares and complications, leading to hospitalization and surgery.

The incidence and prevalence of CD have been increasing worldwide. Data suggest that the incidence rate of CD varies between 0.1 and 20/100,000 persons worldwide.[@B1][@B2][@B3][@B4] The prevalence of CD ranges from 10 to 505 per 100,000 people, and North American studies have shown a prevalence as high as 200 per 100,000 people.[@B5][@B6][@B7] The incidence and prevalence rates of CD have continued to rise in other areas, such as Asia and the developing world, that previously had much lower rates.[@B8][@B9] Many epidemiological studies have shown that the incidence of CD is increasing in Korea. Most previous studies based on data collected from medical facilities in Seoul have examined clinical features such as sex distribution, disease location, and disease behavior in Korean CD patients compared to Caucasian patients.[@B9][@B10][@B11][@B12][@B13][@B14][@B15] The aim of this study was to assess the epidemiological and clinical features of CD in a study population in Busan and Gyeongnam and to compare the results with those of studies conducted at other Korean medical facilities and world institutions.

METHODS
=======

1. Study Population
-------------------

This was a hospital-based study of all cases of CD diagnosed from 1986 to 2013 and followed in seven tertiary care hospitals (Gyeongsang National University Hospital, Kosin University Gospel Hospital, Dong-A University Hospital, Pusan National University Hospital, Inje University Busan Paik Hospital, Pusan National University Yangsan Hospital, and Inje University Haeundae Paik Hospital) in Busan and Gyeongnam, Korea. In total, 619 patients were diagnosed with definite CD in these hospitals. This study was approved by the institutional review board.

2. Methods
----------

This was a retrospective, observational study based on the medical records of patients in multiple centers. Patients were diagnosed with CD if they met at least two of the following criteria: (1) a history of abdominal pain, weight loss, malaise, diarrhea, and/or rectal bleeding, (2) endoscopic findings of mucosal cobble-stoning, linear ulceration, skip areas, or perianal disease, (3) radiologic findings of stricture, fistula, mucosal cobble-stoning, or ulceration, (4) macroscopic appearance of bowel wall induration, mesenteric lymphadenopathy, and \"creeping fat\" on laparotomy, and (5) pathology findings of transmural inflammation and/or epithelioid granulomas.[@B16] We reviewed the age at diagnosis, sex of patients, and the location and behavior of the disease. Other medical records including patient medical history, the presence of perianal fistula, previous anti-tuberculosis (TB) medication use, use of immunosuppressants (Azathioprine/6-mercaptopurine \[AZA/6-MP\]) and biologic agents (anti-tumor necrosis factor \[TNF\]-α inhibitor), and intestinal resection were obtained. Patients were sub-grouped based on the location and presentation of disease following the Montreal classification criteria.[@B17] The location criteria (L1, small bowel; L2, colon; L3, small bowel and colon; L4, isolated upper disease) and behavioral attributes (B1, inflammatory; B2, structuring; B3, penetrating) of the disease were noted for each patient.[@B18] Based on the predominant clinical, radiological, endoscopic, and surgical features, each patient was classified into one of the three patterns.

3. Statistics
-------------

All statistical analyses were conducted using SPSS software (ver. 18.0; SPSS Inc., Chicago, IL, USA). Depending on the characteristics of the data, frequencies such as mean, median, and SD were calculated for numerical variables, and number and percentages were calculated for categorical variables. Fisher\'s exact test, χ^2^ analysis, and Student\'s *t*-test were used to calculate differences and correlation of variables. All the significant variables (*P*-values\<0.1) from univariate analysis (age, sex, disease location, disease behavior and perianal disease) were assessed for correlation to risk of intestinal resection by multiple logistic regression analysis. *P*-values \<0.05 were considered to indicate statistical significance. The cumulative probability of intestinal resection was calculated using the Kaplan-Meier method.

RESULTS
=======

1. Demographic Characteristics
------------------------------

The number of patients with CD included in the study was 619. The number of newly detected cases of patients diagnosed with CD demonstrated a trend of a progressive increase ([Fig. 1](#F1){ref-type="fig"}).

The median age at diagnosis was 24 (range, 5-75) years and the mean age (±SD) was 27 (±11.99) years; 95 (15.3%) patients were aged \<16 years, 444 (71.7%) were aged 17-40 years, and 80 (12.9%) were aged \>40 years. The male-to-female ratio in the patient group was 2.5:1 ([Fig. 2](#F2){ref-type="fig"}). The median duration of follow-up was 62±52.26 (range, 1-324) months. The demographic characteristics of the patients at diagnosis are summarized in [Table 1](#T1){ref-type="table"}.

2. Previous Administration of Anti-TB Medication
------------------------------------------------

In the study group, 45 patients (7.3%) had received anti-TB medication, based on the clinical impression of intestinal TB (ITB) or for differentiating ITB from CD. Anti-TB therapy was not effective in any of the treated patients and all 45 patients were ultimately diagnosed with CD. We divided the patients who were diagnosed with CD during recent 12 years into two groups (2002-2007 and 2008-2013), there were significant differences between the two groups in the frequency of patients misdiagnosed with ITB (12.7% and 5.9%, *P*=0.04).

3. Location and Behavior of Disease
-----------------------------------

The procedures used for the evaluation of disease location at diagnosis included colonoscopy in 607 patients (98.1%), CT in 432 patients (69.8%) , small bowel series in 394 patients (63.7%), esophagogastroduodenoscopy in 47 patients (7.6%), double-contrast barium enema in 21 patients (3.4%), bowel surgery in 14 patients (2.3%), capsule endoscopy in 8 patients (1.3%).

The isolated small bowel (L1) in 114 patients (18.4%), isolated colon (L2) in 144 patients (23.3%), and small bowel and colon (L3) in 358 patients (57.8%) were observed to be the affected regions. Only 3 patients (0.5%) presented with isolated upper disease and 11(1.8%) presented with more distal disease concomitant with upper disease.

Patients presenting with ileo-colonic disease were significantly younger (25.8±11.3 years) than patients presenting with ileal or colonic disease (28.2±11.5 and 29.3±13.6 years, respectively; *P*=0.02).

Disease presentation at diagnosis was inflammatory (B1) in 424 patients (68.5%), stricturing (B2) in 89 (14.4%), and penetrating (B3) in 106 (17.1%). Of the patients initially presenting with B1 type disease, 96 (22.6%) progressed to more aggravated disease behavior by their last evaluation; 45 (10.6%) were B2, and 51 (12%) were B3. In the patients who had disease behavior changes, 81 (84%) patients had ileo-colonic disease, 72 (75%) were male, and median age of patients was 23 (range, 13-66) years. However, after adjusting for other variables, there was no statistically significant difference between patients who showed behavioral change and who did not.

There were 132 (21.3%) patients who presented with active perianal fistulas or reported a history of perianal fistulas. The patients presenting with perianal fistulas exhibited a higher proportion of penetrating disease (8.8% vs. 47.7%, *P*\<0.01), ileo-colonic disease (55.4% vs. 65.2%, *P*=0.02). Of the patients aged ≤16 years (A1), 29 (31.3%) presented with perianal fistulas (A2: 20.1%, A3: 9.3%, *P*\<0.01).

4. Intestinal Resection
-----------------------

In total, 111 patients (17.9%) underwent intestinal resection, with a cumulative probability of intestinal resection 1, 5, 10, and 20 years after diagnosis corresponding to 10.3%, 14.0%, 16.7%, and 36.9%, respectively ([Fig. 3](#F3){ref-type="fig"}). Male sex, older patients, and patients presenting with ileal disease seemed to have an association with intestinal resection but multiple logistic regression analysis revealed that only two significant factors associated with a higher incidence of surgery: disease behavior at diagnosis (*P*\<0.01) and, absence of perianal fistula (*P*\<0.01) ([Table 2](#T2){ref-type="table"}). Overall intestinal resection rate was 17.9%, while 52 (54.2%) out of 96 patients who had progressed to more aggravated disease behaviors underwent intestinal resection.

The intestinal resection rate of AZA/6-MP users was 16.4% (49/298), which was not significantly different from that of AZA/6-MP non-users (15.3% \[49/321\], *P*=0.079). Regarding anti-TNF-α agents, there were no differences in intestinal resection rate between users and non-users (22.4% \[22/98\] vs. 14.6% \[76/521\], *P*=0.359).

DISCUSSION
==========

This large, multi-center study of 619 CD cases from Busan and Gyeongnam in Korea assessed the age at diagnosis, sex, disease location, disease behavior presence of perianal fistulas, use of AZA/6-MP and anti-TNF-α agents, and the characteristics of patients who underwent intestinal resections. The median age at diagnosis of CD was 24 years; this finding is similar to that of previous studies from other countries, which report the median age at diagnosis of CD to be approximately the mid-twenties.[@B14][@B19][@B20][@B21] The male-to-female ratios in previous Korean epidemiological studies ranged from 2.2:1 to 2.8:1, similar to that in this study.[@B13][@B22][@B23][@B24][@B25]

As the etio-pathogenesis of CD remains unclear, the reason for the increased incidence remains unclear. However yet unknown environmental factors may be involved in the development of the disease and improvements in diagnostic procedures and practices may be contributing to the increased detection of the disease.

The distinction between CD and ITB is a diagnostic challenge as both diseases present with similar clinical, radiological, endoscopic, and histological features.[@B26] In these cases, a more precise diagnosis is vital to avoid inadequate anti-TB therapy in patients with CD and potentially unsafe immunosuppressive treatment in patients with ITB. We expect that the therapeutic trial rate of anti-TB medication in patients with CD will decrease further as the incidence of ITB gradually decreases and the incidence and awareness of CD increases in Korea. In this study, 7.3% of patients with CD were prescribed a therapeutic trial of anti-TB medication before they were ultimately diagnosed with CD. This figure was lower than the 36%-47% reported in previous Korean studies.[@B7][@B13][@B27] Advanced diagnostic techniques such as capsule endoscopy, small bowel enteroscopy, and immunological assays for *Mycobacterium tuberculosis* have played an important role in differentiating ITB and CD.[@B28]

The proportion of patients presenting with ileo-colonic disease was similar to findings in previous Korean studies, where the number of L3 was about two-thirds of CD patients.[@B13][@B15][@B23] The proportion of isolated colonic disease (23.3%) in our study population was higher than that in previous Korean studies (8.3%, 12.4%, and 14.4%).[@B15][@B23][@B24] In our study, small bowel involvement of patients presenting with isolated colonic disease was mainly performed by using CT. The patients who had no small bowel involvement in CT were considered as isolated colonic disease without other specific studies. Patients with mild small bowel inflammation that was not detected on CT might have been classified as L2. The exact proportion of patients with L2 could be lower than what is shown in the results of this study. In a few epidemiological studies, isolated upper gastrointestinal disease has been mentioned, but the number of patients was very low, as in this study.[@B17][@B29] In addition, patients presenting with upper gastrointestinal disease that coexisted with more distal disease in our study were fewer than those reported in other studies (12%, 17.8%, and 23.4%).[@B24][@B30][@B31] Because esophagogastroduodenoscopy and wireless capsule endoscopy for investigations of upper gastrointestinal involvement were not performed on all patients, this proportion could not be clearly defined and more complete evaluation of upper gastrointestinal (GI) disease would be required for more precise future analysis.

Ninety-six of 424 patients (22.6%) presenting with inflammatory disease behavior had disease behavior changes, such that 47% of overall patients presented with stricturing or penetrating disease at their final evaluation in this study. In a Norwegian population-based 10-year follow-up study, the overall percentage of patients with stricturing or penetrating disease behavior was 36% at diagnosis, and 53% at 10 years.[@B29] Fifty-four of 191 patients (28.3%) initially showing B1-type behavior demonstrated other types at the last evaluation; 50.7% of patients presented with stricturing or penetrating disease behavior in another Korean study.[@B15] Early detection and advanced medical treatment could contribute to the reduction in aggravation of disease behavior.

The proportion of patients who underwent intestinal resection during the follow-up period was lower than that previously reported in western countries and in Korea. In western population-based studies, the 10-year cumulative probability of bowel resection was 65% in Copenhagen,[@B32] and 37.9% in Norway.[@B29] In a recent study conducted in Denmark, the decrease in surgical intervention was paralleled by an increase in the administration of AZA and anti-TNF-α blockers.[@B33] A 5-year cumulative probability of a first major surgery decreased from 44.7% in a cohort diagnosed with CD during 1979-1986 to 19.6% in a cohort diagnosed from 2003 to 2011.[@B33] In previous Korean studies, the 10-year cumulative probability of bowel resection was 32.8%, 43.5%.[@B15][@B27] In contrast to a previous Danish study, a recent study reported that the early use of infliximab did not reduce CD-related surgery requirements in Korean patients with CD.[@B34] Risk factors for intestinal resection including ileal location, stricturing, or penetrating disease behavior, and younger age have been identified in several studies.[@B24][@B35][@B36][@B37][@B38][@B39] In our study population, a significant correlation between complicated disease behavior and bowel surgery was present but other variables were not statistically significant.

One weakness of the present study is that this was a retrospective, observational study based on the medical records of patients who were diagnosed with CD in multiple centers, data regarding of smoking, interval from symptom to diagnosis, and family history were not extensively collected for all patients. Hospital-based studies compared to populationbased cohort studies may overestimate disease characteristics in patients. There is also a possibility of referral bias and better clinical outcomes, because patients who have intractable disease may undergo treatment at specialized clinics in Seoul.

In conclusion, a continued increase in the number of patients diagnosed with CD was found in Busan and Gyeongnam, as reported in other regions in Korea. We report results similar to those of other Korean studies in terms of sex distribution, age, and location of disease. The probability of the need for surgery was lower and complicated disease behavior developed in fewer cases than expected. A significant correlation between complicated disease behavior and bowel surgery was present. Future analyses of these patients will be required to determine the course of the disease in this population.

**Financial support:** None.

**Conflict of interest:** None.

![Cumulative frequency. The number of cases of patients diagnosed with CD increased over time.](ir-14-30-g001){#F1}

![Age and sex distribution at diagnosis of CD. The incidence of the 20--29-year-old age group for male and female was highest.](ir-14-30-g002){#F2}

![Cumulative probability of intestinal resection during follow-up. It was 10.3%, 14.0%, 16.7%, and 36.9% at 1, 5, 10 and 20 years.](ir-14-30-g003){#F3}

###### Clinical Characteristics of Patients With CD at Diagnosis and Follow-up
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  Characteristics at diagnosis           n=619
  -------------------------------------- ------------
  Male gender                            440 (71.1)
  Age^a^                                 
  Median age at diagnosis (yr)           24
   A1                                    95 (15.3)
   A2                                    444 (71.7)
   A3                                    80 (12.9)
  Disease location at diagnosis^a^       
   L1                                    114 (18.4)
   L2                                    144 (23.3)
   L3                                    358 (57.8)
   Isolated L4                           3 (0.5)
  Disease behavior at diagnosis^a^       
   B1                                    424 (68.5)
   B2                                    89 (14.4)
   B3                                    106 (17.1)
  Perianal fistula                       132 (21.3)
  Previous anti-tuberculous medication   45 (7.3)

  Follow-up results            
  ---------------------------- ------------
  Duration of follow-up (mo)   62.0±52.3
  Medication and surgery       
   Intestinal resection        111 (17.9)
   AZA or 6-MP                 298 (48.1)
   Anti-TNF-α agent            98 (15.8)

Values are presented as mean±SD or n (%).

^a^Age, disease location, and disease behavior in CD based on the Montreal classification.

A1, \<17; A2, 17≤age≤40; A3, \>40; L1, ileal; L2, colonic; L3, ileocolonic; L4, upper gastrointestinal; B1, non-stricturing, non-penetrating; B2, stricturing; B3, penetrating.

AZA, azathioprine; 6-MP, 6-mercaptopurine; TNF, tumor necrosis factor.

###### Univariate and Multivariate Analysis for Factors Associated With Intestinal Resection

![](ir-14-30-i002)

  -------------------------------------------------------------------
  Variable              Univariate\   Multivariate          
                        *P*-value                           
  --------------------- ------------- --------------------- ---------
  Sex                                                       

   Male^a^                                                  

   Female               0.075         0.92 (0.53--1.59)     0.780

  Age at diagnosis^b^                                       

   A1^a^                                                    

   A2                   0.041         1.59 (0.74--3.42)     0.220

   A3                   0.052         1.64 (0.63--4.30)     0.300

  Location^b^                                               

   L1^a^                                                    

   L2                   0.280         0.79 (0.42--1.49)     0.470

   L3                   0.030         0.86 (0.51--1.47)     0.590

  Behavior^b^                                               

   B1^a^                                                    

   B2                   \<0.001       12.00 (6.80--21.17)   \<0.001

   B3                   \<0.001       14.53 (7.56--27.92)   \<0.001

  Perianal fistula      0.008         0.24 (0.11--0.47)     \<0.001
  -------------------------------------------------------------------

^a^Reference categories for OR estimation.

^b^Age, disease location, and disease behavior in CD based on the Montreal classification.

A1, \<17; A2, 17≤age≤40; A3, \>40; L1, ileal; L2, colonic; L3, ileocolonic; B1, non-stricturing, non-penetrating; B2, stricturing; B3, penetrating.
